2024-2029 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for over 40 Transfusion/Immunohematology Tests
This database from LeadingMarketResearch.com provides the 2024 supplier shares, the 2024-2029 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT
More Publications
2024 Haiti Clinical Chemistry and Immunodiagnostics Market--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
US$ 1,850.00
January 2024
-
2019-2023 Global Nucleic Acid Testing/NAT Market: Supplier Shares by Country, Sales Forecasts and Strategic Profiles of Leading Suppliers
US$ 3,500.00
February 2019
109 pages
2024 Italy Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
US$ 3,500.00
August 2024
-
2015-2019 Alternative Scenarios of the Future In Vitro Diagnostics Industry: Business-as-Usual, Economic Austerity, Technological Breakthroughs
US$ 11,600.00
September 2015
255 pages
